U.S.-listed shares of Novo Nordisk declined in premarket trading Friday on the surprise news that CEO Lars Fruergaard ...

It was a ‘mutual agreement,’ Novo says in a statement. A search for Fruergaard Jørgensen’s successor is ongoing.

Making weight loss injections available to all eligible individuals in the U.K. could yield an economic boost of 4.5 billion ...

Demand has soared for treatments targeting the less alluring effects of getting skinny quick. Make your appointment, stat!